{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:56:36Z","timestamp":1791932196097,"version":"4.3.4"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-09171-9","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T06:04:25Z","timestamp":1765087465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Medium-chain triglycerides and ketogenic diet prevent alterations of the gut microbiome in transgenic Alzheimer\u2019s disease mice"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0013-5241","authenticated-orcid":false,"given":"Paule E. H.","family":"M\u2019Bra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5324-3827","authenticated-orcid":false,"given":"Isaura","family":"Su\u00e1rez-Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6796-2453","authenticated-orcid":false,"given":"Mariano","family":"Avino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Ng Kwan Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Mayhue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Balthazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Aumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Pr\u00e9vost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5253-1415","authenticated-orcid":false,"given":"Eric","family":"Mass\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7520-8306","authenticated-orcid":false,"given":"Karl J. L.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"9171_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.exger.2006.05.016","volume":"42","author":"L Mosconi","year":"2007","unstructured":"Mosconi, L. et al. Early detection of Alzheimer\u2019s disease using neuroimaging. Exp. Gerontol. 42, 129\u2013138 (2007).","journal-title":"Exp. Gerontol."},{"key":"9171_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/alz.12328","volume":"17","author":"AS Association","year":"2021","unstructured":"Association, A. S. 2021 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 17, 327\u2013406 (2021).","journal-title":"Alzheimer\u2019s Dement."},{"key":"9171_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold, S. E. et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat. Rev. Neurol. 14, 168\u2013181 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"9171_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396, 413\u2013446 (2020).","journal-title":"Lancet"},{"key":"9171_CR5","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 397, 1577\u20131590 (2021).","journal-title":"Lancet"},{"key":"9171_CR6","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.trci.2019.06.008","volume":"5","author":"E Trushina","year":"2019","unstructured":"Trushina, E. Alzheimer\u2019s disease mechanisms in peripheral cells: promises and challenges. Alzheimers Dement (N. Y 5, 652\u2013660 (2019).","journal-title":"Alzheimers Dement (N. Y"},{"key":"9171_CR7","doi-asserted-by":"publisher","unstructured":"Fortier, M. et al. A ketogenic drink improves cognition in mild cognitive impairment: results of a 6-month RCT. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1002\/alz.12206 (2020).","DOI":"10.1002\/alz.12206"},{"key":"9171_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13195-021-00783-x","volume":"13","author":"MCL Phillips","year":"2021","unstructured":"Phillips, M. C. L. et al. Randomized crossover trial of a modified ketogenic diet in Alzheimer\u2019s disease. Alzheimer\u2019s Res. Ther. 13, 51 (2021).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"9171_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"19","author":"SC Cunnane","year":"2020","unstructured":"Cunnane, S. C. et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat. Rev. Drug Discov. 19, 609\u2013633 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9171_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","volume":"37","author":"JC Newman","year":"2017","unstructured":"Newman, J. C. & Verdin, E. \u03b2-hydroxybutyrate: a signaling metabolite. Annu Rev. Nutr. 37, 51\u201376 (2017).","journal-title":"Annu Rev. Nutr."},{"key":"9171_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(17)30408-8","volume":"17","author":"K Augustin","year":"2018","unstructured":"Augustin, K. et al. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol. 17, 84\u201393 (2018).","journal-title":"Lancet Neurol."},{"key":"9171_CR12","doi-asserted-by":"publisher","unstructured":"Vandenberghe, C. et al. Medium chain triglycerides modulate the ketogenic effect of a metabolic switch. Front. Nutr. 7, https:\/\/doi.org\/10.3389\/fnut.2020.00003 (2020).","DOI":"10.3389\/fnut.2020.00003"},{"key":"9171_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.747284","volume":"8","author":"TY Lin","year":"2021","unstructured":"Lin, T. Y., Liu, H. W. & Hung, T. M. The ketogenic effect of medium-chain triacylglycerides. Front Nutr. 8, 747284 (2021).","journal-title":"Front Nutr."},{"key":"9171_CR14","doi-asserted-by":"publisher","unstructured":"St-Pierre, V. et al. Plasma ketone and medium chain fatty acid response in humans consuming different medium chain triglycerides during a metabolic study day. Front. Nutr. 6, https:\/\/doi.org\/10.3389\/fnut.2019.00046 (2019).","DOI":"10.3389\/fnut.2019.00046"},{"key":"9171_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jalz.2018.12.017","volume":"15","author":"M Fortier","year":"2019","unstructured":"Fortier, M. et al. A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment. Alzheimer\u2019s Dement. 15, 625\u2013634 (2019).","journal-title":"Alzheimer\u2019s Dement."},{"key":"9171_CR16","doi-asserted-by":"publisher","unstructured":"Bohnen, J. L. B., Albin, R. L. & Bohnen, N. I. Ketogenic interventions in mild cognitive impairment, Alzheimer\u2019s disease, and Parkinson\u2019s disease: a systematic review and critical appraisal. Front. Neurol. 14, https:\/\/doi.org\/10.3389\/fneur.2023.1123290 (2023).","DOI":"10.3389\/fneur.2023.1123290"},{"key":"9171_CR17","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3233\/JAD-180202","volume":"64","author":"E Croteau","year":"2018","unstructured":"Croteau, E. et al. Ketogenic medium chain triglycerides increase brain energy metabolism in Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 64, 551\u2013561 (2018).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"9171_CR18","doi-asserted-by":"publisher","first-page":"e1034","DOI":"10.1093\/nutrit\/nuae098","volume":"83","author":"P Krolak-Salmon","year":"2025","unstructured":"Krolak-Salmon, P. et al. Efficacy and safety of exogenous ketones in people with mild neurocognitive disorder and Alzheimer\u2019s disease: a systematic literature review. Nutr. Rev. 83, e1034\u2013e1048 (2025).","journal-title":"Nutr. Rev."},{"key":"9171_CR19","doi-asserted-by":"publisher","unstructured":"M\u2019Bra, P. E. H. et al. Medium-chain triglycerides improve cognition and systemic metabolism in mouse models of Alzheimer\u2019s disease. Brain. https:\/\/doi.org\/10.1093\/brain\/awaf267 (2025).","DOI":"10.1093\/brain\/awaf267"},{"key":"9171_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","volume":"19","author":"JF Cryan","year":"2020","unstructured":"Cryan, J. F., O\u2019Riordan, K. J., Sandhu, K., Peterson, V. & Dinan, T. G. The gut microbiome in neurological disorders. Lancet Neurol. 19, 179\u2013194 (2020).","journal-title":"Lancet Neurol."},{"key":"9171_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00522-2","volume":"17","author":"D Bairamian","year":"2022","unstructured":"Bairamian, D. et al. Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer\u2019s disease. Mol. Neurodegener. 17, 19 (2022).","journal-title":"Mol. Neurodegener."},{"key":"9171_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-023-00893-2","volume":"22","author":"M Mazandarani","year":"2023","unstructured":"Mazandarani, M., Lashkarbolouk, N., Ejtahed, H.-S. & Qorbani, M. Does the ketogenic diet improve neurological disorders by influencing gut microbiota? A systematic review. Nutr. J. 22, 61 (2023).","journal-title":"Nutr. J."},{"key":"9171_CR23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3233\/JAD-220176","volume":"88","author":"EM Khedr","year":"2022","unstructured":"Khedr, E. M., Omeran, N., Karam-Allah Ramadan, H., Ahmed, G. K. & Abdelwarith, A. M. Alteration of gut microbiota in Alzheimer\u2019s disease and their relation to the cognitive impairment. J. Alzheimers Dis. 88, 1103\u20131114 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"9171_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt, N. M. et al. Gut microbiome alterations in Alzheimer\u2019s disease. Sci. Rep. 7, 13537 (2017).","journal-title":"Sci. Rep."},{"key":"9171_CR25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bbi.2019.05.008","volume":"80","author":"P Liu","year":"2019","unstructured":"Liu, P. et al. Altered microbiomes distinguish Alzheimer\u2019s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav. Immun. 80, 633\u2013643 (2019).","journal-title":"Brain Behav. Immun."},{"key":"9171_CR26","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1016\/j.euroneuro.2018.11.289","volume":"29","author":"N Lopizzo","year":"2019","unstructured":"Lopizzo, N. et al. Identification of gut microbiota signature in Alzheimer\u2019s disease: possible role in influencing peripheral inflammation. Eur. Neuropsychopharmacol. 29, S167\u2013S168 (2019).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"9171_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"A Cattaneo","year":"2017","unstructured":"Cattaneo, A. et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol. Aging 49, 60\u201368 (2017).","journal-title":"Neurobiol. Aging"},{"key":"9171_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2271613","volume":"15","author":"T Zhang","year":"2023","unstructured":"Zhang, T., Gao, G., Kwok, L.-Y. & Sun, Z. Gut microbiome-targeted therapies for Alzheimer\u2019s disease. Gut Microbes 15, 2271613 (2023).","journal-title":"Gut Microbes"},{"key":"9171_CR29","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.3390\/ijms25137379","volume":"25","author":"Y Du","year":"2024","unstructured":"Du, Y. et al. The role of short chain fatty acids in inflammation and body health. Int. J. Mol. Sci. 25, 7379 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"9171_CR30","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1073\/pnas.1016088108","volume":"108","author":"I Kimura","year":"2011","unstructured":"Kimura, I. et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc. Natl Acad. Sci. 108, 8030\u20138035 (2011).","journal-title":"Proc. Natl Acad. Sci."},{"key":"9171_CR31","doi-asserted-by":"publisher","unstructured":"Fusco, W. et al. Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients 15, https:\/\/doi.org\/10.3390\/nu15092211 (2023).","DOI":"10.3390\/nu15092211"},{"key":"9171_CR32","doi-asserted-by":"publisher","unstructured":"Ling, Z. et al. Structural and functional dysbiosis of fecal microbiota in chinese patients with Alzheimer\u2019s disease. Front. Cell Dev. Biol. 8, https:\/\/doi.org\/10.3389\/fcell.2020.634069 (2021).","DOI":"10.3389\/fcell.2020.634069"},{"key":"9171_CR33","doi-asserted-by":"publisher","first-page":"e03458","DOI":"10.1128\/spectrum.03458-22","volume":"11","author":"EM Borsom","year":"2023","unstructured":"Borsom, E. M. et al. Predicting neurodegenerative disease using prepathology gut microbiota composition: a longitudinal study in mice modeling Alzheimer\u2019s disease pathologies. Microbiol. Spectr. 11, e03458\u201303422 (2023).","journal-title":"Microbiol. Spectr."},{"key":"9171_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba0466","volume":"6","author":"C Chen","year":"2020","unstructured":"Chen, C. et al. Gut dysbiosis contributes to amyloid pathology, associated with C\/EBP\u03b2\/AEP signaling activation in Alzheimer\u2019s disease mouse model. Sci. Adv. 6, eaba0466 (2020).","journal-title":"Sci. Adv."},{"key":"9171_CR35","first-page":"326","volume":"15","author":"L Rew","year":"2022","unstructured":"Rew, L., Harris, M. D. & Goldie, J. The ketogenic diet: its impact on human gut microbiota and potential consequent health outcomes: a systematic literature review. Gastroenterol. Hepatol. Bed Bench 15, 326\u2013342 (2022).","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"9171_CR36","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3389\/fmicb.2016.00979","volume":"7","author":"A Rivi\u00e8re","year":"2016","unstructured":"Rivi\u00e8re, A., Selak, M., Lantin, D., Leroy, F. & De Vuyst, L. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol 7, 979 (2016).","journal-title":"Front Microbiol"},{"key":"9171_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ebiom.2019.08.032","volume":"47","author":"R Nagpal","year":"2019","unstructured":"Nagpal, R., Neth, B. J., Wang, S., Craft, S. & Yadav, H. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer\u2019s disease markers in subjects with mild cognitive impairment. EBioMedicine 47, 529\u2013542 (2019).","journal-title":"EBioMedicine"},{"key":"9171_CR38","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.cell.2020.04.027","volume":"181","author":"QY Ang","year":"2020","unstructured":"Ang, Q. Y. et al. Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells. Cell 181, 1263\u20131275.e1216 (2020).","journal-title":"Cell"},{"key":"9171_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104899","volume":"155","author":"X Gong","year":"2021","unstructured":"Gong, X. et al. Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets. Micro. Pathog. 155, 104899 (2021).","journal-title":"Micro. Pathog."},{"key":"9171_CR40","doi-asserted-by":"publisher","first-page":"e01794","DOI":"10.1128\/mbio.01794-22","volume":"13","author":"SJB Dunham","year":"2022","unstructured":"Dunham, S. J. B. et al. Longitudinal analysis of the microbiome and metabolome in the 5xfAD mouse model of Alzheimer\u2019s disease. mBio 13, e01794\u201301722 (2022).","journal-title":"mBio"},{"key":"9171_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo, S. et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409\u2013421 (2003).","journal-title":"Neuron"},{"key":"9171_CR42","doi-asserted-by":"publisher","unstructured":"Javonillo, D. I. et al. Systematic phenotyping and characterization of the 3xTg-AD mouse model of Alzheimer\u2019s disease. Front. Neurosci. 15, https:\/\/doi.org\/10.3389\/fnins.2021.785276 (2022).","DOI":"10.3389\/fnins.2021.785276"},{"key":"9171_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.713726","volume":"13","author":"AL Oblak","year":"2021","unstructured":"Oblak, A. L. et al. Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study. Front Aging Neurosci. 13, 713726 (2021).","journal-title":"Front Aging Neurosci."},{"key":"9171_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13293-023-00536-5","volume":"14","author":"LS Robison","year":"2023","unstructured":"Robison, L. S. et al. Sex differences in metabolic phenotype and hypothalamic inflammation in the 3xTg-AD mouse model of Alzheimer\u2019s disease. Biol. Sex. Differ. 14, 51 (2023).","journal-title":"Biol. Sex. Differ."},{"key":"9171_CR45","doi-asserted-by":"publisher","unstructured":"Peeters, J. et al. Exploring the Microbiome Analysis and Visualization Landscape. Frontiers in Bioinformatics 1, https:\/\/doi.org\/10.3389\/fbinf.2021.774631 (2021).","DOI":"10.3389\/fbinf.2021.774631"},{"key":"9171_CR46","doi-asserted-by":"publisher","unstructured":"Wang, Y. et al. Protective effect of zinc gluconate on intestinal mucosal barrier injury in antibiotics and LPS-induced mice. Front. Microbiol. 15, https:\/\/doi.org\/10.3389\/fmicb.2024.1407091 (2024).","DOI":"10.3389\/fmicb.2024.1407091"},{"key":"9171_CR47","unstructured":"Bliek Tijs, F. V. D. K., Marc Galland. RNA-seq lesson, <https:\/\/github.com\/ScienceParkStudyGroup\/rnaseq-lesson>."},{"key":"9171_CR48","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1093\/bioinformatics\/bts342","volume":"28","author":"J Chen","year":"2012","unstructured":"Chen, J. et al. Associating microbiome composition with environmental covariates using generalized UniFrac distances. Bioinformatics 28, 2106\u20132113 (2012).","journal-title":"Bioinformatics"},{"key":"9171_CR49","doi-asserted-by":"publisher","first-page":"11070","DOI":"10.1073\/pnas.0504978102","volume":"102","author":"RE Ley","year":"2005","unstructured":"Ley, R. E. et al. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. 102, 11070\u201311075 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"9171_CR50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12866-017-1027-1","volume":"17","author":"A Koliada","year":"2017","unstructured":"Koliada, A. et al. Association between body mass index and Firmicutes\/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol 17, 120 (2017).","journal-title":"BMC Microbiol"},{"key":"9171_CR51","doi-asserted-by":"crossref","unstructured":"Cheng, Z., Zhang, L., Yang, L. & Chu, H. The critical role of gut microbiota in obesity. Front. Endocrinol. 13, 1025706 (2022).","DOI":"10.3389\/fendo.2022.1025706"},{"key":"9171_CR52","doi-asserted-by":"publisher","first-page":"13168","DOI":"10.1073\/pnas.0404922101","volume":"101","author":"E Smith","year":"2004","unstructured":"Smith, E. & Morowitz, H. J. Universality in intermediary metabolism. Proc. Natl Acad. Sci. 101, 13168\u201313173 (2004).","journal-title":"Proc. Natl Acad. Sci."},{"key":"9171_CR53","doi-asserted-by":"publisher","first-page":"D445","DOI":"10.1093\/nar\/gkz862","volume":"48","author":"R Caspi","year":"2020","unstructured":"Caspi, R. et al. The MetaCyc database of metabolic pathways and enzymes\u2014a 2019 update. Nucleic Acids Res 48, D445\u2013d453 (2020).","journal-title":"Nucleic Acids Res"},{"key":"9171_CR54","doi-asserted-by":"publisher","unstructured":"O\u2019Callaghan, A. & van Sinderen, D. Bifidobacteria and their role as members of the human gut microbiota. Front. Microbiol. 7, https:\/\/doi.org\/10.3389\/fmicb.2016.00925 (2016).","DOI":"10.3389\/fmicb.2016.00925"},{"key":"9171_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2022.102177","volume":"76","author":"JW Bostick","year":"2022","unstructured":"Bostick, J. W., Schonhoff, A. M. & Mazmanian, S. K. Gut microbiome-mediated regulation of neuroinflammation. Curr. Opin. Immunol. 76, 102177 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"9171_CR56","doi-asserted-by":"crossref","unstructured":"Ross, F. C. et al. The interplay between diet and the gut microbiome: implications for health and disease. Nat. Rev. Microbiol. 22, 671\u2013686 (2024).","DOI":"10.1038\/s41579-024-01068-4"},{"key":"9171_CR57","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s13668-024-00539-7","volume":"13","author":"\u015e Ayten","year":"2024","unstructured":"Ayten, \u015e. & Bilici, S. Modulation of gut microbiota through dietary intervention in neuroinflammation and Alzheimer\u2019s and Parkinson\u2019s diseases. Curr. Nutr. Rep. 13, 82\u201396 (2024).","journal-title":"Curr. Nutr. Rep."},{"key":"9171_CR58","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s10571-022-01226-3","volume":"43","author":"D Dilimulati","year":"2023","unstructured":"Dilimulati, D. et al. Ketogenic diet modulates neuroinflammation via metabolites from Lactobacillus reuteri after repetitive mild traumatic brain injury in adolescent mice. Cell. Mol. Neurobiol. 43, 907\u2013923 (2023).","journal-title":"Cell. Mol. Neurobiol."},{"key":"9171_CR59","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1021\/acs.jproteome.5b01025","volume":"15","author":"MS Klein","year":"2016","unstructured":"Klein, M. S. et al. Metabolomic modeling to monitor host responsiveness to gut microbiota manipulation in the BTBRT+tf\/j mouse. J. Proteome Res. 15, 1143\u20131150 (2016).","journal-title":"J. Proteome Res."},{"key":"9171_CR60","doi-asserted-by":"publisher","unstructured":"Vacca, M. et al. The controversial role of human gut lachnospiraceae. Microorganisms 8, https:\/\/doi.org\/10.3390\/microorganisms8040573 (2020).","DOI":"10.3390\/microorganisms8040573"},{"key":"9171_CR61","doi-asserted-by":"publisher","unstructured":"You, H. et al. The therapeutic effect of SCFA-mediated regulation of the intestinal environment on obesity. Front. Nutr. 9, https:\/\/doi.org\/10.3389\/fnut.2022.886902 (2022).","DOI":"10.3389\/fnut.2022.886902"},{"key":"9171_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13446","volume":"9","author":"K Shcherbakova","year":"2023","unstructured":"Shcherbakova, K. et al. Short- and long-term cognitive and metabolic effects of medium-chain triglyceride supplementation in rats. Heliyon 9, e13446 (2023).","journal-title":"Heliyon"},{"key":"9171_CR63","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neulet.2018.10.048","volume":"690","author":"M Ota","year":"2019","unstructured":"Ota, M. et al. Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer\u2019s disease. Neurosci. Lett. 690, 232\u2013236 (2019).","journal-title":"Neurosci. Lett."},{"key":"9171_CR64","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1039\/D2FO03059D","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. Dietary additive octyl and decyl glycerate modulates metabolism and inflammation under different dietary patterns with the contribution of the gut microbiota. Food Funct. 14, 525\u2013540 (2023).","journal-title":"Food Funct."},{"key":"9171_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01549-0","volume":"9","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson\u2019s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome. Cell Death Discov. 9, 251 (2023).","journal-title":"Cell Death Discov."},{"key":"9171_CR66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jbiotec.2022.09.011","volume":"359","author":"J Zhou","year":"2022","unstructured":"Zhou, J. et al. An acetate-independent pathway for isopropanol production via HMG-CoA in Escherichia coli. J. Biotechnol. 359, 29\u201334 (2022).","journal-title":"J. Biotechnol."},{"key":"9171_CR67","doi-asserted-by":"publisher","first-page":"e0278276","DOI":"10.1371\/journal.pone.0278276","volume":"17","author":"JH Jung","year":"2022","unstructured":"Jung, J. H. et al. Gut microbiome alterations in preclinical Alzheimer\u2019s disease. PLoS ONE 17, e0278276 (2022).","journal-title":"PLoS ONE"},{"key":"9171_CR68","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jalz.2019.07.002","volume":"15","author":"B Li","year":"2019","unstructured":"Li, B. et al. Mild cognitive impairment has similar alterations as Alzheimer\u2019s disease in gut microbiota. Alzheimer\u2019s Dement. 15, 1357\u20131366 (2019).","journal-title":"Alzheimer\u2019s Dement."},{"key":"9171_CR69","doi-asserted-by":"publisher","unstructured":"Yu, B. et al. Disruptions of gut microbiota are associated with cognitive deficit of preclinical Alzheimer\u2019s disease: a cross-sectional study. Curr. Alzheimer Res. https:\/\/doi.org\/10.2174\/0115672050303878240319054149 (2024).","DOI":"10.2174\/0115672050303878240319054149"},{"key":"9171_CR70","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1111\/ene.15961","volume":"30","author":"G Chen","year":"2023","unstructured":"Chen, G., Zhou, X., Zhu, Y., Shi, W. & Kong, L. Gut microbiome characteristics in subjective cognitive decline, mild cognitive impairment and Alzheimer\u2019s disease: a systematic review and meta-analysis. Eur. J. Neurol. 30, 3568\u20133580 (2023).","journal-title":"Eur. J. Neurol."},{"key":"9171_CR71","doi-asserted-by":"publisher","first-page":"13665","DOI":"10.3390\/ijms232213665","volume":"23","author":"B Bonnech\u00e8re","year":"2022","unstructured":"Bonnech\u00e8re, B., Amin, N. & van Duijn, C. What are the key gut microbiota involved in neurological diseases? A systematic review. Int. J. Mol. Sci. 23, 13665 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"9171_CR72","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s11011-024-01369-w","volume":"39","author":"JP Fabi","year":"2024","unstructured":"Fabi, J. P. The connection between gut microbiota and its metabolites with neurodegenerative diseases in humans. Metab. Brain Dis. 39, 967\u2013984 (2024).","journal-title":"Metab. Brain Dis."},{"key":"9171_CR73","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-180176","volume":"63","author":"Z-Q Zhuang","year":"2018","unstructured":"Zhuang, Z.-Q. et al. Gut microbiota is altered in patients with Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 63, 1337\u20131346 (2018).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"9171_CR74","doi-asserted-by":"publisher","unstructured":"Haran J., P. et al. Alzheimer\u2019s disease microbiome is associated with dysregulation of the anti-inflammatory P-glycoprotein pathway. mBio 10, https:\/\/doi.org\/10.1128\/mbio.00632-00619 (2019).","DOI":"10.1128\/mbio.00632-00619"},{"key":"9171_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.942460","volume":"12","author":"L Chen","year":"2022","unstructured":"Chen, L. et al. A comparison of the composition and functions of the oral and gut microbiotas in Alzheimer\u2019s patients. Front. Cell. Infect. Microbiol. 12, 942460 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"9171_CR76","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3233\/JAD-215090","volume":"87","author":"S Jeong","year":"2022","unstructured":"Jeong, S. et al. Cognitive function associated with gut microbial abundance in sucrose and S-adenosyl-L-methionine (SAMe) metabolic pathways. J. Alzheimer\u2019s Dis. 87, 1115\u20131130 (2022).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"9171_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01768-2","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Ma, M., Dai, W., Shang, Q. & Yu, G. Bacteroides salyersiae is a potent chondroitin sulfate-degrading species in the human gut microbiota. Microbiome 12, 41 (2024).","journal-title":"Microbiome"},{"key":"9171_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42312-w","volume":"13","author":"K He","year":"2023","unstructured":"He, K., Liu, M., Wang, Q., Chen, S. & Guo, X. Combined analysis of 16S rDNA sequencing and metabolomics to find biomarkers of drug-induced liver injury. Sci. Rep. 13, 15138 (2023).","journal-title":"Sci. Rep."},{"key":"9171_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00720-0","volume":"19","author":"Y-X Luo","year":"2024","unstructured":"Luo, Y.-X., Yang, L.-L. & Yao, X.-Q. Gut microbiota-host lipid crosstalk in Alzheimer\u2019s disease: implications for disease progression and therapeutics. Mol. Neurodegener. 19, 35 (2024).","journal-title":"Mol. Neurodegener."},{"key":"9171_CR80","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1515\/revneuro-2020-0146","volume":"32","author":"J-z Lin","year":"2021","unstructured":"Lin, J. -z, Duan, M. -r, Lin, N. & Zhao, W. -j The emerging role of the chondroitin sulfate proteoglycan family in neurodegenerative diseases. Rev. Neurosci. 32, 737\u2013750 (2021).","journal-title":"Rev. Neurosci."},{"key":"9171_CR81","doi-asserted-by":"publisher","first-page":"S267","DOI":"10.3233\/JAD-221076","volume":"94","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y. et al. Effects of S-adenosylmethionine on cognition in animals and humans: a systematic review and meta-analysis of randomized controlled trials. J. Alzheimers Dis. 94, S267\u2013s287 (2023).","journal-title":"J. Alzheimers Dis."},{"key":"9171_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2022.112045","volume":"172","author":"IE Futschek","year":"2023","unstructured":"Futschek, I. E., Schernhammer, E., Haslacher, H., St\u00f6gmann, E. & Lehrner, J. Homocysteine\u2014a predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer\u2019s dementia. Exp. Gerontol. 172, 112045 (2023).","journal-title":"Exp. Gerontol."},{"key":"9171_CR83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2110387118","volume":"118","author":"AA Parkhitko","year":"2021","unstructured":"Parkhitko, A. A. et al. A genetic model of methionine restriction extends Drosophila health- and lifespan. Proc. Natl Acad. Sci. 118, e2110387118 (2021).","journal-title":"Proc. Natl Acad. Sci."},{"key":"9171_CR84","doi-asserted-by":"publisher","first-page":"477","DOI":"10.18632\/aging.203826","volume":"14","author":"CC Hung","year":"2022","unstructured":"Hung, C. C., Chang, C. C., Huang, C. W., Nouchi, R. & Cheng, C. H. Gut microbiota in patients with Alzheimer\u2019s disease spectrum: a systematic review and meta-analysis. Aging 14, 477\u2013496 (2022).","journal-title":"Aging"},{"key":"9171_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38218-7","volume":"9","author":"N Saji","year":"2019","unstructured":"Saji, N. et al. Analysis of the relationship between the gut microbiome and dementia: a cross-sectional study conducted in Japan. Sci. Rep. 9, 1008 (2019).","journal-title":"Sci. Rep."},{"key":"9171_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.32959","volume":"195","author":"D Mateo","year":"2024","unstructured":"Mateo, D., Marqu\u00e8s, M., Domingo, J. L. & Torrente, M. Influence of gut microbiota on the development of most prevalent neurodegenerative dementias and the potential effect of probiotics in elderly: a scoping review. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 195, e32959 (2024).","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"9171_CR87","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/nu13010228","volume":"13","author":"L Wu","year":"2021","unstructured":"Wu, L. et al. Altered gut microbial metabolites in amnestic mild cognitive impairment and Alzheimer\u2019s disease: signals in host\u2013microbe interplay. Nutrients 13, 228 (2021).","journal-title":"Nutrients"},{"key":"9171_CR88","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.aca.2019.04.021","volume":"1070","author":"J Zheng","year":"2019","unstructured":"Zheng, J. et al. Stable isotope labeling combined with liquid chromatography-tandem mass spectrometry for comprehensive analysis of short-chain fatty acids. Anal. Chim. Acta 1070, 51\u201359 (2019).","journal-title":"Anal. Chim. Acta"},{"key":"9171_CR89","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129\u201310140 (2006).","journal-title":"J. Neurosci."},{"key":"9171_CR90","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.brainres.2010.06.011","volume":"1348","author":"R Sterniczuk","year":"2010","unstructured":"Sterniczuk, R., Antle, M. C., Laferla, F. M. & Dyck, R. H. Characterization of the 3xTg-AD mouse model of Alzheimer\u2019s disease: part 2. Behavioral and cognitive changes. Brain Res. 1348, 149\u2013155 (2010).","journal-title":"Brain Res."},{"key":"9171_CR91","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12642","volume":"15","author":"MK Differding","year":"2020","unstructured":"Differding, M. K. et al. Potential interaction between timing of infant complementary feeding and breastfeeding duration in determination of early childhood gut microbiota composition and BMI. Pediatr. Obes. 15, e12642 (2020).","journal-title":"Pediatr. Obes."},{"key":"9171_CR92","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12866-020-01724-8","volume":"20","author":"T Ch\u00e9nard","year":"2020","unstructured":"Ch\u00e9nard, T., Malick, M., Dub\u00e9, J. & Mass\u00e9, E. The influence of blood on the human gut microbiome. BMC Microbiol. 20, 44 (2020).","journal-title":"BMC Microbiol."},{"key":"9171_CR93","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1128\/AEM.00684-07","volume":"74","author":"Z Yu","year":"2008","unstructured":"Yu, Z., Garc\u00eda-Gonz\u00e1lez, R., Schanbacher, F. L. & Morrison, M. Evaluations of different hypervariable regions of archaeal 16S rRNA genes in profiling of methanogens by Archaea-specific PCR and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 74, 889\u2013893 (2008).","journal-title":"Appl. Environ. Microbiol."},{"key":"9171_CR94","doi-asserted-by":"publisher","first-page":"808","DOI":"10.2144\/04365ST04","volume":"36","author":"Z Yu","year":"2004","unstructured":"Yu, Z. & Morrison, M. Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques 36, 808\u2013812 (2004).","journal-title":"Biotechniques"},{"key":"9171_CR95","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1462-2920.2005.00933.x","volume":"8","author":"Z Yu","year":"2006","unstructured":"Yu, Z., Yu, M. & Morrison, M. Improved serial analysis of V1 ribosomal sequence tags (SARST-V1) provides a rapid, comprehensive, sequence-based characterization of bacterial diversity and community composition. Environ. Microbiol. 8, 603\u2013611 (2006).","journal-title":"Environ. Microbiol."},{"key":"9171_CR96","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/ismej.2012.8","volume":"6","author":"JG Caporaso","year":"2012","unstructured":"Caporaso, J. G. et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 6, 1621\u20131624 (2012).","journal-title":"ISME J."},{"key":"9171_CR97","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1128\/AEM.01043-13","volume":"79","author":"JJ Kozich","year":"2013","unstructured":"Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K. & Schloss, P. D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ. Microbiol 79, 5112\u20135120 (2013).","journal-title":"Appl Environ. Microbiol"},{"key":"9171_CR98","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1038\/ismej.2017.119","volume":"11","author":"BJ Callahan","year":"2017","unstructured":"Callahan, B. J., McMurdie, P. J. & Holmes, S. P. Exact sequence variants should replace operational taxonomic units in marker-gene data analysis. Isme j. 11, 2639\u20132643 (2017).","journal-title":"Isme j."},{"key":"9171_CR99","unstructured":"Paulson J. N. et al. metagenomeSeq: Statistical Analysis for Sparse High-Throughput Sequencing, <http:\/\/www.cbcb.umd.edu\/software\/metagenomeSeq> (2013)."},{"key":"9171_CR100","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/nmeth.2658","volume":"10","author":"JN Paulson","year":"2013","unstructured":"Paulson, J. N., Stine, O. C., Bravo, H. C. & Pop, M. Differential abundance analysis for microbial marker-gene surveys. Nat. Methods 10, 1200\u20131202 (2013).","journal-title":"Nat. Methods"},{"key":"9171_CR101","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLOS ONE 8, e61217 (2013).","journal-title":"PLOS ONE"},{"key":"9171_CR102","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"9171_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-020-00160-w","volume":"6","author":"H Lin","year":"2020","unstructured":"Lin, H. & Peddada, S. D. Analysis of microbial compositions: a review of normalization and differential abundance analysis. NPJ Biofilms Microbiomes 6, 60 (2020).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"9171_CR104","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.12688\/f1000research.27893.1","volume":"9","author":"CW Law","year":"2020","unstructured":"Law, C. W. et al. A guide to creating design matrices for gene expression experiments. F1000Res 9, 1444 (2020).","journal-title":"F1000Res"},{"key":"9171_CR105","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43, e47 (2015).","journal-title":"Nucleic Acids Res"},{"key":"9171_CR106","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","volume":"38","author":"GM Douglas","year":"2020","unstructured":"Douglas, G. M. et al. PICRUSt2 for prediction of metagenome functions. Nat. Biotechnol. 38, 685\u2013688 (2020).","journal-title":"Nat. Biotechnol."},{"key":"9171_CR107","doi-asserted-by":"publisher","unstructured":"Yang, C. et al. ggpicrust2: an R package for PICRUSt2 predicted functional profile analysis and visualization. Bioinformatics 39, https:\/\/doi.org\/10.1093\/bioinformatics\/btad470 (2023).","DOI":"10.1093\/bioinformatics\/btad470"},{"key":"9171_CR108","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan, J. & Kantharia, N. D. How to calculate sample size in animal studies? J. Pharm. Pharmacother. 4, 303\u2013306 (2013).","journal-title":"J. Pharm. Pharmacother."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09171-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09171-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09171-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T14:01:50Z","timestamp":1766584910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09171-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9171"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-09171-9","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1814"}}